Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading
developer of spider silk based fibers, announces today the creation of
the next generation of recombinant spider silk using the Company’s new
design, gene editing, and incorporation approaches. Kraig Labs designed
this approach to customize mechanical properties for specific commercial
markets and has demonstrated the ability to more quickly, accurately,
and efficiently, generate new transgenics.
This is the material science breakthrough that the Company has been
pushing for since establishing the Dragon Silk line; this new transgenic
was specifically engineered for high strength and significantly higher
protein expression levels. This achievement marks a significant
milestone in Kraig Labs’ mission to produce and commercialize
eco-friendly materials that exceed the performance and strength of
native spider silk.
“This breakthrough has powerful ramifications that affect the core of
how we develop future spider silk materials,” said COO Jon Rice. “These
newly confirmed transgenics mark a revolutionary advancement in
capability of our spider silk materials. The new tools developed by Dr.
Trevor Kane and our research team will allow us to target commercial
markets that were not originally on our radar.”
Screening of these samples confirms that the gene edit was successful,
validating the underlying protocols and genetic constructs. Furthermore,
western blot analysis, performed on the silk, confirms expression of
this new and potentially much more powerful spider silk protein. These
results open the door for the Company to deploy this new methodology
towards a variety of tailored spider silk designs. Kraig Labs expects
these new recombinant spider silk fiber lines will open up broader
commercial opportunities and complement the Company’s existing Monster
Silk™ and Dragon Silk™ technologies.
To view the most recent news from Kraig Labs and/or to sign up for
Company alerts, please go to www.KraigLabs.com/news.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com),
a reporting biotechnology company is the leading developer of
genetically engineered spider silk based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the
area of spider silk technology with implications for the global textile
industry.
Cautionary Statement Regarding Forward-Looking Information
Statements in this press release about the Company’s future and
expectations other than historical facts are “forward-looking
statements.” These statements are made on the basis of management’s
current views and assumptions. As a result, there can be no assurance
that management’s expectations will necessarily come to pass. These
forward-looking statements generally can be identified by phrases such
as “believes,” “plans,” “expects,” “anticipates,” “foresees,”
“estimated,” “hopes,” “if,” “develops,” “researching,” “research,”
“pilot,” “potential,” “could” or other words or phrases of similar
import. Forward looking statements include descriptions of the Company’s
business strategy, outlook, objectives, plans, intentions and goals. All
such forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially from
those in forward-looking statements. This press release does not
constitute an offer to sell or the solicitation of an offer to buy any
security.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190530005233/en/